Clinical trials
Huntington Disease trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Terminated | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Johns Hopkins University | 2 |
| Massachusetts General Hospital | 2 |
| Ohio State University | 2 |
| The University of Texas Health Science Center, Houston | 2 |
| University of Virginia | 2 |
| Anne Kloos | 1 |
| Brown, Theodore R., M.D., MPH | 1 |
| Cardiff University | 1 |
| Oregon Health and Science University | 1 |
| The University of Texas Health Science Center at San Antonio | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Huntington Disease | 17 |
| Parkinson Disease | 7 |
| Lewy Body Disease | 4 |
| Alzheimer Disease | 2 |
| Amyotrophic Lateral Sclerosis | 2 |
| Anxiety Disorders | 2 |
| Dementia | 2 |
| Brain Damage, Chronic | 1 |
| Brain Injuries | 1 |
| Cachexia | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.